Background: Deep Brain Stimulation (DBS) of the subgenual cingulate cortex (SCC) is a
Introduction
Major Depressive Disorder is a psychiatric illness regarded as a major cause of disability [1] , with a high worldwide prevalence [2] . Despite the multiple therapeutic approaches currently available to treat depression, including antidepressant drugs, psychotherapy and electroconvulsive therapy (ECT), an important number of patients do not respond satisfactorily to these conventional therapies [3] [4] [5] . Deep Brain Stimulation (DBS) is an innovative and promising technique to treat patients with refractory depression, and clinical evidence suggests that DBS of the subgenual cingulate cortex (SCC) is effective in treating resistant depression [6] [7] [8] . However, the way in which DBS might achieve these effects remains somewhat enigmatic.
In preclinical models, the behavioural and neurobiological effects provoked by DBS of the ventromedial prefrontal cortex (vmPFC, the rodent correlate to human SCC) [9, 10] have been examined (reviewed in: [11] ; and see also [12] [13] [14] [15] [16] [17] [18] [19] [20] ). These studies reported antidepressant-like effects of DBS in behavioural tests that are sensitive to pharmacological antidepressants.
Furthermore, the observation that DBS enhances climbing behaviour and the release of noradrenaline in the area of stimulation [17] suggests a possible engagement of the noradrenergic system in the antidepressant-like activity of DBS in rats.
Neuroanatomical tracing studies in monkeys and rodents indicate that the noradrenergic locus coeruleus (LC) receives projections from the vmPFC [21, 22] , and a negative correlation has been seen between the activity of noradrenergic LC neurons and prefrontal neurons in rats [23, 24] . Furthermore, previous studies indicated that depression and suicide in humans, and depressive-like symptoms in animals, are accompanied by maladaptive plasticity in the noradrenergic system [25] . However, whether and how vmPFC DBS might induce changes in M A N U S C R I P T
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LC activity is not known. Thus, we set out to study the effect of vmPFC DBS on LC activity using a combination of behavioural, electrophysiological and biochemical techniques.
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Material and methods
Animals
Experiments were performed on adult male Wistar rats (weighing 250-350g) that were housed in polycarbonate cages under standard laboratory conditions (22ºC, 12h light/dark cycle, lights on at 08:00 am, food and water ad libitum). Every effort was made to minimize animal suffering and to use the smallest possible number of animals, and all the procedures and animal handling were carried out in accordance with the European Commission's directive 2010/63/EU and Spanish Law (RD 53/2013) regulating animal research. Moreover, the experimental protocols were reviewed and approved by the Committee for Animal Experimentation at the University of Cadiz and all procedures were supervised by a veterinarian in order to guarantee animal welfare.
Two experimental groups of rats were established: control, animals with electrodes implanted and retained in the vmPFC but that received no stimulation; and DBS, animals with electrodes implanted in the vmPFC and to which electrical stimulation was delivered.
Tracer procedure
Animals were anaesthetized (ketamine 100mg/kg, xylazine 12mg/kg; intraperitoneal, i.p.) and situated nose down in a stereotaxic frame with their head at an angle of 15° to the horizontal plane. The Fluoro-Gold retrograde tracer (FG; Fluorocrome, USA) was microinjected unilaterally into the right LC (anteroposterior [AP] -3.7mm; midline [ML] -1.1mm relative to lambda; and dorsoventral [DV] -6.0mm from brain surface) [26] using glass micropipettes with a 15-20µm diameter tip filled with a 4% FG solution prepared in physiological saline (0.9% NaCl). FG was injected iontophoretically, applying a 7µA alternating current on a 7s duty cycle for 15min through a silver wire inserted in the pipette. The pipette was left in place for an M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 7 additional 5min to avoid tracer leakage along the pipette track. Isotonic sterile saline was administered subcutaneously (s.c.) in all animals to replace the lost fluids. Furthermore, animals received a dose of enrofloxacin and carprofen (both 5 mg/kg, s.c.) during the surgical procedure and this administration was repeated 24 hours later. Seven days after FG microinjection animals were perfused with a 4% paraformaldehyde (PFA) solution and the distribution of the FG in sections (30µm) of the brain area containing the vmPFC and LC were assayed by immunofluorescence to improve the fluorescence detection (Fig. S1A) as described in [27, 28] .
Briefly, sections were incubated for 48h at 4 °C in a 1:1,000 dilution of rabbit anti-FG antiserum (AB153; Millipore, USA). The antibody binding was then revealed with a biotinylated donkey anti-rabbit secondary antibody (1:200; Jackson ImmunoResearch, USA) and a streptavidin Alexa Fluor 488 conjugate (1:1,000; Invitrogen by Thermo Fisher Scientific, USA). Finally, the sections were coveslipped in fluoro-gel aqueous mounting medium and FG-immunoreactivity was captured using a camera connected to an Olympus BX60 microscope (Olympus America, USA) equipped with a U-MNU filter system.
Electrode implantation and DBS procedure
The animals were anaesthetized (ketamine 100mg/kg, xylazine 12mg/kg; i.p.), positioned in the stereotaxic frame and administered with local anaesthesia (lidocaine 3.5 mg/kg, bupivacaine 2 mg/kg; s.c.) to reinforce and extend the anaesthetic effect for 3-4 hours post-surgery. Then, animals were prepared surgically for bilateral implantation of the stimulation electrodes into the vmPFC (AP +3.2mm from bregma, ML ±0.5mm, DV -4.0mm from the dura mater) [19] . In addition, a stainless steel screw was secured onto the skull above the prefrontal cortex (AP +2.7mm from bregma and ML -2.0mm) [26] to record electrocorticogram (ECoG) activity. The M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 8 electrodes were then fixed to three stainless steel screws secured to the skull using dental acrylic cement. Isotonic sterile saline (s.c.) was administered in all animals to replace the lost of fluids.
The bipolar stimulating electrodes were two stainless-steel enamel-coated wires (California Fine Wire, USA) with a 1mm exposed surface. The stimulation protocol involved monophasic square wave pulses delivered by a CS-20 stimulator (Cibertec, Spain), with a current intensity of 100µA, a frequency of 130Hz, and a pulse width of 90µs [15, 19] . The stimulation protocol lasted for 2 days, with animals receiving a 4h stimulation 24h after surgery and a 2h stimulation 48h after surgery [15, 19] . The two electrodes were implanted in control animals that were connected to the stimulator but they received no current pulses.
Forced swimming test (FST)
Rats were placed in clear Plexiglas cylinders (height 50cm; diameter 20cm) filled to a depth of 30cm with tap water at 25 ± 1ºC, initially for a period of 15min in the first swimming session (pre-test) and then for 5min under the same conditions 24h later (test) (Fig. S1B) [29] . The sessions were videotaped and subsequently scored by a trained observer, who was blind to the treatments. The rat's behaviour was assessed at 5s intervals during the test session using customized software (Red Mice, Spain) and at each 5s interval, the predominant behaviour was assigned to one of three categories: immobility, climbing or swimming. Immobility was assigned when the rat remained floating in the water without struggling, only making movements that were necessary to keep its head above water. Climbing was defined as forceful thrashing movements of the forelimbs directed against the walls of the cylinder. Swimming was defined as moving all four paws in an active swimming motion that was more vigorous than is necessary to merely maintain the head above water.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Western blotting
Another set of animals was sacrificed by decapitation immediately after the DBS protocol terminated, and their LC was removed bilaterally and stored at -80°C (Fig. S1C ). This frozen tissue was then solubilised in a 50mM Tris-hydrochloride (pH 7.7) buffer containing protease and phosphatase inhibitor cocktails (P2714 & P5726; Sigma-Aldrich, Spain), and after homogenization, the protein concentration was determined by the Bradford method. Equal amounts of protein from the LC homogenates were then separated by SDS-PAGE (sodium dodecyl sulphate-polyacrylamide gel electrophoresis) and transferred to polyvinylidene difluoride membranes (BioRad, Spain). After washing in Tris-buffered saline containing 0.1% Tween-20 (TBST), the blots were blocked for 1h at room temperature with 5% bovine serum albumin (Sigma-Aldrich, Spain) in TBST and probed overnight at 4°C with the following primary antibodies: rabbit anti-tyrosine hydroxylase (TH, 1:1 000; Thermo Fisher Scientific, USA); rabbit anti-noradrenaline transporter (NAT, 1:100, sc-67216; Santa Cruz Biotechnology, USA); rabbit anti-phospho-extracellular signal-regulated kinase (ERK1/2) (1:5,000; Acris Antibodies, Germany); mouse anti-ERK1/2 (1:2,000; Cell Signaling Technology, USA); goat anti-corticotropin releasing factor (CRF, 1:500, sc-1759; Santa Cruz Biotechnology, USA); rabbit anti-β-actin (1:10,000, A2103; Sigma-Aldrich, Spain); mouse anti-α-tubulin (1:10,000; Sigma-Aldrich, Spain). The membranes were washed and incubated with IRDye ® 800CW goat anti-rabbit, IRDye ® 680LT goat anti-mouse and IRDye ® 800CW donkey anti-goat secondary antibodies (1:10,000; LI-COR Biosciences, USA). Antibody binding was detected using a LI-COR Odyssey ® two-channel quantitative fluorescence imaging system (LI-COR Biosciences, USA) and digital images of the blots were analysed by densitometry using the ImageJ free access software (National Institutes of Health, USA). The data were obtained in arbitrary units of M A N U S C R I P T
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10 optical density and expressed relative to the controls. TH and CRF protein expression was normalized to β-actin as a loading control and that of NAT to α-tubulin. The pERK1/2 was normalized to the corresponding total ERK1/2 as no significant differences between this protein and the loading control (α-tubulin) were observed (Fig. S2) .
Electrophysiological recordings and analysis
Single-unit extracellular recordings of LC neurons were obtained as described previously [30] and immediately after the end of the DBS protocol (Fig. S1D ). The recording electrode, a singlebarrel pulled glass micropipette filled with a 2% solution of Pontamine Sky Blue in 0.5% sodium acetate, was lowered into the LC (AP -3.7mm, ML -1.1mm relative to lambda and 5.5-6.5mm
from the brain surface) [26] . The extracellular signals from the electrode were amplified with a high-input impedance amplifier and monitored. Discriminated spikes were fed into a PC and processed using CED Micro1401 and Spike2 computer software (Cambridge Electronic Design, Cambridge, UK). LC neurons were identified on the basis of well-established criteria [31] : long action potentials (> 2ms), spontaneous firing at a regular rhythm, a slow firing rate between 0.5 and 5Hz, and characteristic spikes with a long-lasting positive-negative waveform. When a single unit was isolated, the spontaneous firing activity was recorded for at least 2min prior to the response evoked by mechanical stimulation. Several LC neurons were recording from each animal and only the last neuron in each rat was tested pharmacologically.
For tonic LC activity, the following parameters were assessed in over a constant 100s period: the spontaneous firing rate (Hz); the burst incidence (% of neurons that presented burst firing); and the mean spike number per burst. A LC cell was considered to exhibit burst firing when it M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
11 displayed at least two spikes with an initial interspike interval < 80ms and with subsequent interspike intervals ≤ 160ms [32] . The sensory-evoked response of LC neurons was recorded in a maximum of 8 neurons per animal after recording the basal spontaneous activity. Accordingly, a single mechanical compression of the contralateral hindpaw was applied for 1.0s using an 18.0cm Tennis needle holder (Ref. WI 103-044; Weldon Instruments, Pakistan), the same investigator applying constant pressure midway along the forceps each time. This kind of stimulus was sufficient to induce a LC response and no sensitization or habituation is thought to be induced by repeated exposure [33, 34] . Thus, this stimulus evoked a "burst" discharge followed by post-activation inhibition or suppression period [35] (Fig. 1A) . A LC neuron was considered to exhibit a sensory-evoked response when it displayed at least two spikes with an interspike interval ≤160 ms. This response was assessed in terms of: (i) incidence, the proportion of cells exhibiting a sensory-evoked response; (ii) mean spike number per evoked response; (iii) duration (s), the time between the first and last spike of the evoked response; and (iv) suppression period (s), the time after each evoked response in which there was no neuronal activity.
To study the effect of DBS on the activity of the alpha2-adrenoceptors in the LC, dose-response curves were obtained with the alpha2-adrenoceptor agonist UK14,304 (2.5-80µg/kg). UK14,304
was injected intravenously (i.v.), with doubling doses administered at 1 min intervals until all the spontaneous activity ceased (maximal effect). Subsequent injection of the selective alpha2-adrenoceptor antagonist, RX821002 (100µg/kg; Sigma, Spain), was administered to reverse the inhibition of LC neuronal activity. The changes in firing rate provoked by UK14,304 were M A N U S C R I P T
12 expressed as the reduction relative to the basal firing rate and those due to RX821002 were expressed as the recovery of the firing rate from total inhibition (0%) to that basal state (100%).
Based on the relationship between the electrical activity of LC neurons and the prefrontal cortex described previously [23, 24, 36] , the effect of DBS on slow oscillations from the LC and prefrontal cortex was evaluated. For this purpose, the local field potentials (LFP) in the LC and ECoG signal from the prefrontal cortex screw were recorded simultaneously and immediately after the end of the DBS protocol (Fig. S1D) , amplified (2,000 and 20,000, respectively), filtered (0.3-100Hz) and sampled (2.5 KHz) online, and stored in a computer connected to the Micro1401 CED interface for offline analysis using the Spike2 software. The power spectra for the LFP and ECoG recordings were constructed using Fast Fourier Transformations (FFT) of 100s signal intervals corresponding to the baseline, with a resolution of 0.3Hz (FFT size of 8192). The data are given as the area under the curve of the power spectra for the low frequency bands: delta (δ), <4Hz; theta (θ), 4-10Hz. For a coherence analysis, LFP and ECoG waveforms with 8,192 points were assessed (the same 100s period for both waveforms) with a custom script for the Spike2 software that yields a frequency resolution of 0.3 Hz. Finally, the temporal coincidence of the discharge spikes of LC neurons in the up-phase of the ECoG waveform was examined with another ad hoc script for the Spike2 software in the same 100s period used for LFP and ECoG analysis [37] . The ECoG signal was first down sampled and then low-pass filtered using the finite impulse response (FIR) to obtain the <4 and 4-10Hz frequency bands required to determine the percentage of spikes above ECoG.
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Histological verification
At the end of the experiments, the placement of the electrode tips in the vmPFC was confirmed histologically and the recording site was marked by passing a 5µA cathode current through the electrode to leave a blue spot. Briefly, fixed brain sections (40µm) were stained with neutral red and examined microscopically (Fig. 1B, C) . Those animals whose electrodes or Pontamine Sky
Blue spot were incorrectly located were not included in the analysis.
Drugs
UK14,304 (Tocris Bioscience, UK) and RX821002 hydrochloride (Sigma-Aldrich, Spain) were dissolved in physiological saline (0.9% NaCl) and the doses used were selected on the basis of previous successful experiments carried out in our laboratory and from data available in the literature. The range of doses of UK14,304 has been demonstrated to completely inhibit the firing rate of LC neurons [38] and the dose of RX821002 was previously shown to block the effect alpha2-adrenoceptor agonists on LC neurons [30, 39] .
Statistical analysis
All the data are presented as the mean ± S.E.M. The results from the forced swimming test, protein expression, tonic and evoked firing activity of LC neurons, RX821002 reversion, LC-LFP and ECoG power spectrum and coherence were analysed using an unpaired Student's t-test.
A one-way repeated measures analysis of variance (ANOVA) followed by Fisher LSD post-hoc test was used to analyse the UK14,304 dose-response curves. The incidence of burst and evoked signals were analysed using a Fisher's exact test. The differences were considered significant at p<0.05. The statistical analysis and the results were summarized in Table S1 .
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Results
Tracer study
Iontophoretic injection of the retrograde FG tracer revealed a small injection site located in the right LC (Fig. 1D) . When analysed seven days after injection, retrograde labelled neurons were evident in layers V-VI of the vmPFC (Fig. 1E, S3) , confirming that the LC receives input from this structure.
Forced Swimming Test
The antidepressant-like effect of vmPFC DBS was assessed in the FST (see experimental design
in Fig. 1F ), revealing a significant reduction of immobility behaviour in DBS rats with respect to the control rats (p<0.01; Fig. 1G ). This reduction in immobility was accompanied by an increase in climbing behaviour in these animals (p<0.01; Fig. 1G ), although no significant differences were observed in swimming behaviour in the rats that were subjected to vmPFC DBS (p>0.05; Fig. 1G ).
Protein expression in the Locus Coeruleus
DBS significantly increased TH expression in the LC relative to the control animals (p<0.05; Fig. 1H ), whereas there were no alterations to the NAT protein (p>0.05; Fig. 1H ). By contrast, DBS provoked a reduction in the phosphorylation of ERK in the LC relative to the control animals (p<0.001; Fig. 1H ). It should be noted that the expression of ERK did not change between each groups of animals (p>0.05; Fig. S2 ) and likewise, there was no difference in the amount of CRF in the LC of DBS relative to the control rats (p>0.05; Fig. 1H ).
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Single-unit extracellular recording of Locus Coeruleus neurons
LC neurons were recorded under anaesthesia just after the DBS protocol ended. An analysis of the isolated units ( Fig. 2A) showed that there was a significantly higher spontaneous firing rate in the DBS group than in the animals that did not receive stimulation (p<0.01; Fig. 2B , Table 1 ).
However, there was no effect of DBS on bursting activity (Table 1) , a Fisher's exact test revealing no differences in burst incidence between the groups (p>0.05; Table 1 ) and an unpaired Student's t-test showing that the mean spikes per burst were also unaltered by DBS (p>0.05; Table 1 ).
The evoked activity of LC neurons to paw compression was evaluated (Fig. 1A, Fig. 2C -E, Table   1 ) and there was a positive response to this mechanical stimulus in the majority of LC neurons from both control and stimulated animals. However, while a similar incidence of evoked responses was observed in both groups (p>0.05; Table 1 ), the duration of the responses was significantly longer in the animals that received DBS than in the control animals (p<0.05; Fig.   2C , Table 1 ). Accordingly, DBS animals tended to have more spikes per response (p>0.05; Fig.   2D , Table 1 ), and a significantly shorter period of suppression compared to the unstimulated animals (p<0.01; Fig. 2E ; Table 1 ).
Dose-response curves to UK14,304 were generated to evaluate alpha2-adrenoceptor activity in stimulated and unstimulated animals. Increasing doses of UK14,304 administered intravenously produced a progressive reduction in the firing rate in both control rats and those that received DBS (Fig. 2F ). However, a significant effect of DBS was observed on the inhibition of LC units ( Fig. 2F -G, Table 1 ). One-way repeated measures ANOVA revealed significant effects of both DBS (p<0.05) and increasing doses of UK14,304 (p<0.001). Thus, UK14,304 showed a weaker inhibitory effect in DBS than in control animals at doses of 10 and 20µg/kg (p<0.05, p<0.01,
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16 respectively; Fig. 2G , Table 1 ). Subsequent intravenous administration of RX821002 produced a similar reversal effect in both experimental groups (control, 130.1 ± 9.4 and DBS, 103.9 ± 14.2, p>0.05; Table 1) .
LC-LFP, ECoG and coherence
The effect of DBS on the LC and prefrontal cortical network activity was examined by evaluating the power spectra of the LC-LFP and of the ECoG activity in the prefrontal cortex. As such, LC-LFP spectrograms displaying a power spectrum at low frequencies (0-10Hz) were clearly affected by DBS at all the frequency ranges represented compared to those in the controls (Fig. 3A) . Indeed, the power spectrum analysis of LC-LFP revealed a significant effect between the two experimental groups, showing a robust increase of power produced by DBS in both frequency bands assessed: <4Hz (p<0.001; Fig. 3B ) and 4-10Hz (p<0.01; Fig. 3B ). By contrast, the ECoG spectrograms did not show any differences between the DBS and control animals ( Fig.   3C ). Thus, electrical stimulation did not appear to modify cortical power in either the <4 or 4-10Hz bands (p>0.05; Fig. 3D ).
The effect of DBS on the coherence between the LC and prefrontal cortex was also evaluated with the aim to describe how DBS affected rhythmic brain activity between these areas. When the mean LC-PFC coherence values for <4 and 4-10Hz were represented (Fig. 3E-F) , the coherence in the <4Hz band was significantly stronger in DBS animals compared to controls (p<0.001; Fig. 3E-F) . Conversely, DBS produced a significant reduction in the 4-10Hz frequency band compared to the control animals (p<0.01; Fig. 3E-F) .
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Discussion
The present study demonstrates that DBS delivered to the vmPFC activates the LC and produces an antidepressant-like effect in the FST. The protocol of DBS delivered to the vmPFC produced an antidepressant-like effect that was reflected by a significant reduction in immobility behaviour in the FST, the most widely used paradigm to predict antidepressant activity in rodents. This antidepressant-like effect was consistent with earlier preclinical reports using the same DBS protocol in the vmPFC [15, 19] . DBS also provoked a significant increase in climbing behaviour when active movements in the FST were analysed, which has been related to enhanced noradrenaline bioavailability [29, 40] . Indeed, it has been demonstrated that DBS of the vmPFC induces a local increase of noradrenaline (to around 150%), which remains elevated after DBS ceases [17] . These data suggest the involvement of noradrenergic neurotransmission in the antidepressant-like effect of DBS. This participation of the noradrenergic system contrasts with data obtained using the noradrenergic neurotoxin DSP-4 [15] , although it is important to note that several off target effects have been proposed for this neurotoxin [41] . Furthermore, vmPFC DBS seems to activate the noradrenergic system as DBS specifically enhances TH expression in the LC, the rate-limiting enzyme in catecholamine biosynthesis, and it increases the spontaneous firing rate of LC neurons. Conversely, since the NAT in the LC is not affected by DBS, vmPFC DBS appears to enhance noradrenergic neurotransmission, increasing the production of this neurotransmitter without altering its reuptake. Moreover, DBS dampened ERK phosphorylation that suggests more limited MAPK pathway activation in the LC. Hence, DBS could exert a protective effect against the consequences of stress. Indeed, the activation of this intracellular signalling cascade has been related to affective symptoms [42, 43] and its inhibition with an M A N U S C R I P T
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18 antidepressant-like effect [44] [45] [46] . In addition, and as expected, DBS did not alter the levels of CRF in the LC, a neurotransmitter involved in stressful responses [47] .
DBS enhanced the sensory-evoked response to paw compression and the longer duration of the evoked response was associated with a trend to increase the number of LC spikes per response, in conjunction with a shorter suppression period. The increase in the evoked response to sensory stimuli provoked by DBS could be explained by alpha2-adrenoceptors desensitization [48, 49] .
Indeed, the activity of alpha2-adrenoreceptors was weaker in the LC following vmPFC DBS as revealed by the UK14,304 dose-response curves after DBS. The lower activity of alpha2-adrenoreceptors could be derived from a desensitization or a reduction in their expression in the LC [50] induced by vmPFC DBS, being necessary further studies to discern this specific point.
Both desensitization and a decreased number of alpha2-adrenoreceptors would contribute to a higher tonic discharge rate and LC responsiveness to sensory stimuli, as observed in this study.
Alpha2-adrenoreceptors mediate the negative feedback inhibition of noradrenergic activity and it has been suggested that blocking these receptors enhances the antidepressant-like effect of monoamines reuptake inhibitors [51] . Hence, it is that a short DBS protocol can dampen alpha2-adrenoreceptors activity.
The relationship between the therapeutic effects of DBS and the changes in neural oscillations was evaluated by assessing the effects of DBS on the low frequency oscillations associated with the LC-LFP and ECoG [52] [53] [54] . LFP recordings detect the integrated activity of neuronal networks surrounding the electrode, providing a measure of oscillations due to synchronised neuronal activity. This network activity is assumed to be fundamental for neural communication.
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The power spectrum analysis revealed that DBS increased LC-LFP in both the frequency bands assessed, <4 and 4-10Hz, usually referred to as the delta and theta components of LFP. LFP in other brain areas are also enhanced after vmPFC DBS, such as in the hippocampus and amygdala [55] . By contrast, the power spectrum from the ECoG signal was not modified by DBS, neither at <4Hz nor 4-10Hz. Although DBS did not change low frequency ECoG oscillations, a coherence analysis between the LC and prefrontal cortex showed that vmPFC DBS caused clear differences in the coherence pattern. These differences involved enhanced coherence in the <4Hz frequency band, accompanied by significantly impaired coherence in the 4-10Hz band.
Importantly, the effect of DBS on LC-prefrontal cortex coherence is exactly the opposite to that produced by stress [56] . Hence, the changes to prefrontal cortex-LC coherence induced by DBS would suggest an improvement in neural communication between these brain structures that could be protective in stressful situations. Note that the results of this mechanistic study have been obtained in healthy animals. Thus, it would be very interesting to perform further studies to know the effect of vmPFC DBS on LC after a stressful situation or in an animal model of depression.
Our data suggest that vmPFC DBS promotes an antidepressant-like effect together with a general LC activation including the electrical activity of LC neurons and its responsiveness to sensory stimuli. This activation was accompanied by an increase in TH expression and no changes in NAT, suggesting that DBS exerts an increase in noradrenaline synthesis that seems to be released in the vmPFC [17] but no significant changes in the LC noradrenaline reuptake.
Additionally, DBS exert a LC-PFC network modulation increasing the coherence of these two UK14,304 (selective alpha2-adrenoceptors agonist) dose-response curves were performed only hoc test: *p<0.05, **p<0.01 and ***p<0.001 vs control animals (see Table 1 for the number of neurons and animals used for tonic and evoked LC activity, n=5 LC cells from 5 animals per group were analysed for UK14,304 dose-response curves). Abbreviations: DBS, deep brain stimulation. 
